Purdue Pharma and the Sackler families reached a settlement with a group of states this week that would require the Sacklers to pay out as much as $6 billion to states, individual claimants and ...

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024.If approved, the new plan would end the ...

Purdue Pharma and the members of the Sackler family who own the company agreed in principle to pay a $7.4 billion settlement to resolve thousands of lawsuits over their alleged role in the opioid ...

Purdue Pharma, Sacklers reach new settlement agreement in opioid cases by Nathaniel Weixel - 01/23/25 3:39 PM ET. by Nathaniel Weixel - 01/23/25 3:39 PM ET.

Purdue Pharma and the Sackler family reach $6 billion OxyContin settlement The deal, hashed out over weeks of intense negotiations, raises the amount paid by the Sacklers by more than $1 billion ...

All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma, maker of Oxycontin, over the company's improper marketing of opioids.

Under the new terms, a significant amount of the settlement funds will be distributed in the first three years, with the Sacklers paying $1.5 billion and Purdue paying nearly $900 million in the ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid ...

Purdue Pharma and its Sackler family owners reached a $7.4 billion opioid settlement. The deal allows lawsuits against the Sacklers, who will pay $6.5 billion.

Purdue Pharma, Sacklers reach new $7.4 billion opioid settlement. All 50 states as well as the District of Columbia and U.S. territories have approved a $7.4 billion settlement with Purdue Pharma ...